Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avid Bioservices Inc CDMO

Healthcare Biotechnology
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services... see more

Recent & Breaking News (NDAQ:CDMO)

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2020 and Recent Developments

GlobeNewswire June 30, 2020

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2020 After Market Close on June 30, 2020

GlobeNewswire June 23, 2020

Avid Bioservices Names Nicholas Green as President and Chief Executive Officer

GlobeNewswire June 23, 2020

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

GlobeNewswire June 3, 2020

Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing

GlobeNewswire May 6, 2020

Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia

GlobeNewswire April 13, 2020

Avid Bioservices Receives Five 2020 CMO Leadership Awards

GlobeNewswire March 26, 2020

Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments

GlobeNewswire March 10, 2020

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

GlobeNewswire March 4, 2020

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020

GlobeNewswire March 3, 2020

Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer

GlobeNewswire January 8, 2020

Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments

GlobeNewswire December 9, 2019

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

GlobeNewswire December 4, 2019

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019

GlobeNewswire December 2, 2019

Avid Bioservices Names Richard Richieri as Chief Operations Officer

GlobeNewswire October 9, 2019

Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure

GlobeNewswire October 8, 2019

Avid Bioservices Announces Termination of Stockholder Rights Plan

GlobeNewswire September 23, 2019

Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments

GlobeNewswire September 5, 2019

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

GlobeNewswire September 4, 2019

Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019

GlobeNewswire August 29, 2019